The Heart Pump Devices Market in APAC - Forecast to 2025: Opportunities in Emerging Countries - ResearchAndMarkets.com
Aug. 23, 2018
DUBLIN--(BUSINESS WIRE)--Aug 23, 2018--The "Asia-Pacific Heart Pump Devices Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
Asia-Pacific heart pump devices market is expected to reach USD 756.15 million by 2025 and is projected to register a healthy CAGR in the forecast period 2018 to 2025.
Prominent factors driving the growth of this market consist of increasing incidence of cardiac disease, rapid advancement in surgical technique in VAD implantation, increasing popularity of minimal invasive surgical procedures in cardiology, regulatory approval of heart pump devices are fuel the growth of heart pump devices market.
On the basis of product the Asia-Pacific heart pump devices market is segmented into ventricular assist devices, intra-aortic balloon pump, total artificial heart (TAH). In 2018, intra-aortic balloon pumps are expected to dominate the Asia-Pacific heart pump devices market with highest market shares. However, ventricular assist devices are expected to grow at the highest CAGR in the forecast period.
On the basis of type the Asia-Pacific heart pump devices market is categorized into implantable heart pump devices and extracorporeal heart pump devices. In 2018, implantable heart pump devices are expected to dominate the Asia-Pacific heart pump devices market with the highest CAGR in the forecast period 2018 to 2025.
On the basis of therapy Asia-Pacific heart pump devices market is segmented into bridge-to-transplant (BTT), bridge-to-candidacy (BTC) destination therapy and others. In 2018, bridge-to-transplant (BTT) are expected to dominate the Asia-Pacific heart pump devices market with the highest CAGR in the forecast period 2018 to 2025.
DriversIncreasing Incidence of Cardiac Diseases Increasing Regulatory Approval & Reimbursement Procedure of Heart Pump Devices Rapid Advancement in Surgical Technique for VAD Implantation Increasing Popularity of Minimally Invasive Surgical Procedures in Cardiology
RestraintHigh Cost of Process & Product
ChallengeComplications Related to LVAD
Companies ProfiledAbbott Getinge AB Teleflex Incorporated Abiomed Berlin Heart BiVACOR Inc. Calon Cardio CardiacAssist Inc. Jarvik Heart Inc. Medtronic ReliantHeart Inc. SynCardia Systems LLC Terumo Corporation Thoratec Corporation
For more information about this report visit https://www.researchandmarkets.com/research/x7fb2r/the_heart_pump?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180823005368/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Cardiovascular Devices
KEYWORD: ASIA PACIFIC
INDUSTRY KEYWORD: HEALTH CARDIOLOGY MEDICAL DEVICES
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 08/23/2018 08:01 AM/DISC: 08/23/2018 08:02 AM